High Throughput Combinatorial Formatting of PcrV Nanobodies for Efficient Potency Improvement

Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii : Mechanisms and epidemiology

(2015) Anaïs Potron et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

A Novel Anti-PcrV Antibody Providing Enhanced Protection against Pseudomonas aeruginosa in Multiple Animal Infection Models

(2014) Paul Warrener et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Multivalent nanobodies targeting death receptor 5 elicit superior tumor cell killing through efficient caspase induction

(2014) Heather A Huet et al.   mAbs

V-antigen homologs in pathogenic gram-negative bacteria

(2014) Teiji Sawa et al.   MICROBIOLOGY AND IMMUNOLOGY

Protective Effect of Different Anti-Rabies Virus VHH Constructs against Rabies Disease in Mice

(2014) Sanne Terryn et al.   PLoS One

A multifunctional bispecific antibody protects against Pseudomonas aeruginosa

(2014) A. DiGiandomenico et al.   Science Translational Medicine

Nanobodies: Natural Single-Domain Antibodies

(2013) Serge Muyldermans   Annual Review of Biochemistry

A novel effector secretion mechanism based on proton-motive force-dependent type III secretion apparatus rotation

(2013) Takashi Ohgita et al.   FASEB JOURNAL

Llama-derived Single Variable Domains (Nanobodies) Directed against Chemokine Receptor CXCR7 Reduce Head and Neck Cancer Cell Growthin Vivo

(2013) David Maussang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

In the Absence of Effector Proteins, the Pseudomonas aeruginosa Type Three Secretion System Needle Tip Complex Contributes to Lung Injury and Systemic Inflammatory Responses

(2013) Jonathon P. Audia et al.   PLoS One

Protein Export According to Schedule: Architecture, Assembly, and Regulation of Type III Secretion Systems from Plant- and Animal-Pathogenic Bacteria

(2012) D. Buttner   MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS

A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth

(2011) Rob C. Roovers et al.   INTERNATIONAL JOURNAL OF CANCER

Anti-Pseudomonas aeruginosa serotype O11 LPS immunoglobulin M monoclonal antibody panobacumab (KBPA101) confers protection in a murine model of acute lung infection

(2011) T. Secher et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Llama-Derived Single Domain Antibodies to Build Multivalent, Superpotent and Broadened Neutralizing Anti-Viral Molecules

(2011) Anna Hultberg et al.   PLoS One

Crystal Structure of PrgI-SipD: Insight into a Secretion Competent State of the Type Three Secretion System Needle Tip and its Interaction with Host Ligands

(2011) Michele Lunelli et al.   PLoS Pathogens

Multi-Functional Characteristics of the Pseudomonas aeruginosa Type III Needle-Tip Protein, PcrV; Comparison to Orthologs in other Gram-negative Bacteria

(2011) Hiromi Sato et al.   Frontiers in Microbiology

Control of effector export by thePseudomonas aeruginosatype III secretion proteins PcrG and PcrV

(2010) Pei-Chung Lee et al.   MOLECULAR MICROBIOLOGY

CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells

(2010) S. Jahnichen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Protective effects of affinity-purified antibody and truncated vaccines againstPseudomonas aeruginosaV-antigen in neutropenic mice

(2009) Kiyoshi Moriyama et al.   MICROBIOLOGY AND IMMUNOLOGY

The type III secretion system of Pseudomonas aeruginosa: infection by injection

(2009) Alan R. Hauser   NATURE REVIEWS MICROBIOLOGY

An Engineered Human Antibody Fab Fragment Specific for Pseudomonas aeruginosa PcrV Antigen Has Potent Antibacterial Activity

(2008) M. Baer et al.   INFECTION AND IMMUNITY

Oligomerization of PcrV and LcrV, Protective Antigens ofPseudomonas aeruginosaandYersinia pestis

(2008) Gébus Caroline et al.   JOURNAL OF BIOLOGICAL CHEMISTRY